Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran Lipid and Glucose Study

被引:0
|
作者
M. Bozorgmanesh
F. Hadaegh
F. Sheikholeslami
F. Azizi
机构
[1] Shahid Beheshti University of Medical Sciences,Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences
来源
Journal of Endocrinological Investigation | 2012年 / 35卷
关键词
All-cause mortality; cardiovascular disease; diabetes; population attributable fraction; risk;
D O I
暂无
中图分类号
学科分类号
摘要
Aim: To quantify the burden of cardiovascular diseases (CVD), and all-cause mortality attributable to diabetes. Subjects and methods: Data on an 8.6-yr follow-up of 6331 participants (2741 men), free of CVD at baseline, were analyzed to determine the burden of CVD and all-cause mortality attributable to self-reported and screen-detected diabetes mellitus (SRDM and SDDM, respectively). Risks of events of interest were separately assessed for women and men using Cox-proportional-hazard model. Results: The mean age at baseline was 47 yr with 997 (15.7%) of participants having diabetes (men 14.8%, women 16.5%). SRDM and SDDM prevailed in 9.7% (men 9.2, women 10.2%) and 6.0% of participants (men 5.7, women 6.3%), respectively. During follow up (52,404 person-yr), we observed 447 incident cases of CVD [387 had coronary heart disease (CHD)] and 209 deaths. Among men, participants with SDDM had increased relative hazard for all-cause mortality translated to a population attributable risk fraction (PAF) of 10.1%. Among women, SDDM was associated with CVD and CHD but not with all-cause mortality; so that 9.3% and 8.8% of CVD and CHD events were respectively attributable to the SDDM. If SRDM had been eliminated from the population, the incidences of CVD, CHD, and death would have decreased by 10.5, 9.5, and 17.3% in men; and 22.0, 24.2, and 17.8% in women, respectively. Conclusion: SDDM and SRDM have high PAF for all-cause mortality and CVD. Besides diabetes treatment and prevention, screening to detect undiagnosed diabetes should warrant high priority among the public health strategies to lower the incidence of CVD and mortality.
引用
收藏
页码:14 / 20
页数:6
相关论文
共 50 条
  • [11] Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality
    Bancks, Michael P.
    Carson, April P.
    Lewis, Cora E.
    Gunderson, Erica P.
    Reis, Jared P.
    Schreiner, Pamela J.
    Yano, Yuichiro
    Carnethon, Mercedes R.
    DIABETOLOGIA, 2019, 62 (08) : 1366 - 1374
  • [12] Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate
    Hulman, Adam
    Vistisen, Dorte
    Glumer, Charlotte
    Bergman, Michael
    Witte, Daniel R.
    Faerch, Kristine
    DIABETOLOGIA, 2018, 61 (01) : 101 - 107
  • [13] Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study
    Raffield, Laura M.
    Hsu, Fang-Chi
    Cox, Amanda J.
    Carr, J. Jeffrey
    Freedman, Barry I.
    Bowden, Donald W.
    DIABETOLOGY & METABOLIC SYNDROME, 2015, 7
  • [14] Association of cumulative blood glucose load with cardiovascular risk and all-cause mortality
    Tian, Xue
    Chen, Shuohua
    Zhang, Yijun
    Zhang, Xiaoli
    Xu, Qin
    Xia, Xue
    Wang, Penglian
    Luo, Yanxia
    Wu, Shouling
    Wang, Anxin
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (12)
  • [15] Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease
    Kraus, William E.
    Powell, Kenneth E.
    Haskell, William L.
    Janz, Kathleen F.
    Campbell, Wayne W.
    Jakicic, John M.
    Troiano, Richard P.
    Sprow, Kyle
    Torres, Andrea
    Piercy, Katrina L.
    Buchner, David M.
    DiPietro, Loretta
    Erickson, Kirk, I
    Hillman, Charles H.
    Katzmarzyk, Peter T.
    King, Abby C.
    Macko, Richard F.
    Marquez, David X.
    McTieman, Anne
    Pate, Russell R.
    Pescatello, Linda S.
    Whitt-Glover, Melicia C.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2019, 51 (06) : 1270 - 1281
  • [16] Time course of the triglyceride glucose index accumulation with the risk of cardiovascular disease and all-cause mortality
    Tian, Xue
    Chen, Shuohua
    Zhang, Yijun
    Zhang, Xiaoli
    Xu, Qin
    Wang, Penglian
    Wu, Shouling
    Wang, Anxin
    Luo, Yanxia
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [17] Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study
    Sillars, B.
    Davis, W. A.
    Hirsch, I. B.
    Davis, T. M. E.
    DIABETES OBESITY & METABOLISM, 2010, 12 (09) : 757 - 765
  • [18] Time course of the triglyceride glucose index accumulation with the risk of cardiovascular disease and all-cause mortality
    Xue Tian
    Shuohua Chen
    Yijun Zhang
    Xiaoli Zhang
    Qin Xu
    Penglian Wang
    Shouling Wu
    Anxin Wang
    Yanxia Luo
    Cardiovascular Diabetology, 21
  • [19] Predictive Value of Triglyceride-Glucose Index for All-Cause and Cardiovascular Mortality in Patients With Diabetes Mellitus: A Retrospective Study
    Feng, Xiaoxuan
    Deng, Yishou
    Chen, Chaolei
    Liu, Xiaocong
    Huang, Yuqing
    Feng, Yingqing
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2024, 2024
  • [20] Association of early-onset diabetes, prediabetes and early glycaemic recovery with the risk of all-cause and cardiovascular mortality
    Kim, Sung Min
    Lee, Gyeongsil
    Choi, Seulggie
    Kim, Kyuwoong
    Jeong, Su-Min
    Son, Joung Sik
    Yun, Jae-Moon
    Kim, Sin Gon
    Hwang, Seung-sik
    Park, Seong Yong
    Kim, Yeon-Yong
    Park, Sang Min
    DIABETOLOGIA, 2020, 63 (11) : 2305 - 2314